Literature DB >> 112628

Methadone-induced changes in the visual evoked response recorded from multiple sites in the cat brain.

E W Snyder, D E Shearer, R E Dustman, E C Beck.   

Abstract

Visual evoked responses (VERs) and EEG were recorded following the i.p. administration of five doses of methadone (0.5--4 mg/kg) to 12 adult cats, which were implanted with cortical and subcortical electrodes. Additional cats, subjected to the same drug regimen, were used to evaluate plasma methadone concentrations. Doses of methadone that produced plasma concentrations between 80 and 190 ng/ml differentially affected VERs recorded from cortical and subcortical sites. Of the subcortical structures evaluated, the limbic system, specifically the hippocampus, was the most sensitive to the effects of the drug. These effects appeared to be primarily depressant. Responses recorded from the reticular formation and centromedian were affected only by the highest dose of methadone, while VERs recorded from cortical sites were reliably altered following the two highest doses and appeared to reflect both excitation and depression. Behavioral changes, however, were clearly evidenced in some cats at lower doses of methadone. Therefore, the data suggest (1) that those structures evaluated electrophysiologically did not reflect the full force of the drug's action as evidenced by its effect on behavior, (2) that cortical and subcortical recording sites have differential sensitivities, and (3) that one clearly defined, principal size of action of methadone is absent in the cat.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112628     DOI: 10.1007/bf00426927

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  THE INFLUENCE OF MORPHINE AND PETHIDINE ON SOMATIC EVOKED RESPONSES IN THE HIPPOCAMPAL FORMATION OF THE CAT.

Authors:  J S MCKENZIE
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1964-10

2.  Effect of nitrogen narcosis on cortical and subcortical evoked responses in the cat.

Authors:  R T Bartus; J S Kinney
Journal:  Aviat Space Environ Med       Date:  1975-03

3.  Neurophysiological changes in caudate nucleus and substantia nigra following morphine treatment.

Authors:  N Dafny; T F Burks
Journal:  Neuropharmacology       Date:  1976-09       Impact factor: 5.250

4.  Role of central dopaminergic receptors in manic response of cats to morphine.

Authors:  K M Dhasmana; K S Dixit; B P Jaju; M L Gupta
Journal:  Psychopharmacologia       Date:  1972

5.  The effect of methadone on hippocampal EEG.

Authors:  G Benignus; F J Bremner; V Benignus; T Vice
Journal:  Neuropsychologia       Date:  1974-01       Impact factor: 3.139

6.  Brain sites of precipitated abstinence in morphine-dependent rats.

Authors:  E Wei; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-04       Impact factor: 4.030

7.  The effects of morphine, morphinone and thebaine on the EEG and behavior of rabbits and cats.

Authors:  G Navarro; H W Elliott
Journal:  Neuropharmacology       Date:  1971-07       Impact factor: 5.250

8.  Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation.

Authors:  K Jhamandas; M Sutak
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Morphine, naloxone and the responses of medial thalamic neurones of the cat.

Authors:  A W Duggan; J G Hall
Journal:  Brain Res       Date:  1977-02-11       Impact factor: 3.252

10.  Neurophysiological assessment of site specific effects of chronic morphine administration in freely behaving rats.

Authors:  R E McClung; T F Burks; N Dafny
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-09
View more
  1 in total

1.  Cultured rat hippocampal neural progenitors generate spontaneously active neural networks.

Authors:  Sanjay K Mistry; Edward W Keefer; Bruce A Cunningham; Gerald M Edelman; Kathryn L Crossin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.